389 related articles for article (PubMed ID: 36388628)
1. Intestinal Flora Derived Metabolites Affect the Occurrence and Development of Cardiovascular Disease.
Wen Y; Sun Z; Xie S; Hu Z; Lan Q; Sun Y; Yuan L; Zhai C
J Multidiscip Healthc; 2022; 15():2591-2603. PubMed ID: 36388628
[TBL] [Abstract][Full Text] [Related]
2. Update on gut microbiota in cardiovascular diseases.
Qian B; Zhang K; Li Y; Sun K
Front Cell Infect Microbiol; 2022; 12():1059349. PubMed ID: 36439214
[TBL] [Abstract][Full Text] [Related]
3. The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases.
Zhen J; Zhou Z; He M; Han HX; Lv EH; Wen PB; Liu X; Wang YT; Cai XC; Tian JQ; Zhang MY; Xiao L; Kang XX
Front Endocrinol (Lausanne); 2023; 14():1085041. PubMed ID: 36824355
[TBL] [Abstract][Full Text] [Related]
4. The role of intestinal microbiota in cardiovascular disease.
Jin M; Qian Z; Yin J; Xu W; Zhou X
J Cell Mol Med; 2019 Apr; 23(4):2343-2350. PubMed ID: 30712327
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota metabolites as integral mediators in cardiovascular diseases (Review).
Zhu Y; Shui X; Liang Z; Huang Z; Qi Y; He Y; Chen C; Luo H; Lei W
Int J Mol Med; 2020 Sep; 46(3):936-948. PubMed ID: 32705240
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular Health and The Intestinal Microbial Ecosystem: The Impact of Cardiovascular Therapies on The Gut Microbiota.
Alhajri N; Khursheed R; Ali MT; Abu Izneid T; Al-Kabbani O; Al-Haidar MB; Al-Hemeiri F; Alhashmi M; Pottoo FH
Microorganisms; 2021 Sep; 9(10):. PubMed ID: 34683334
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances in Microbiota-Associated Metabolites in Heart Failure.
Masenga SK; Povia JP; Lwiindi PC; Kirabo A
Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626809
[TBL] [Abstract][Full Text] [Related]
8. Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease.
Lu Y; Zhang Y; Zhao X; Shang C; Xiang M; Li L; Cui X
Front Cardiovasc Med; 2022; 9():900381. PubMed ID: 36035928
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota and cardiovascular diseases axis.
Moldovan DC; Ismaiel A; Fagoonee S; Pellicano R; Abenavoli L; Dumitrascu DL
Minerva Med; 2022 Feb; 113(1):189-199. PubMed ID: 33969961
[TBL] [Abstract][Full Text] [Related]
10. Implication of Gut Microbiota in Cardiovascular Diseases.
Zhou W; Cheng Y; Zhu P; Nasser MI; Zhang X; Zhao M
Oxid Med Cell Longev; 2020; 2020():5394096. PubMed ID: 33062141
[TBL] [Abstract][Full Text] [Related]
11. Gut Microbiota in Ischemic Stroke: Role of Gut Bacteria-Derived Metabolites.
Zhang W; Dong XY; Huang R
Transl Stroke Res; 2023 Dec; 14(6):811-828. PubMed ID: 36279071
[TBL] [Abstract][Full Text] [Related]
12. The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation.
Rahman MM; Islam F; -Or-Rashid MH; Mamun AA; Rahaman MS; Islam MM; Meem AFK; Sutradhar PR; Mitra S; Mimi AA; Emran TB; Fatimawali ; Idroes R; Tallei TE; Ahmed M; Cavalu S
Front Cell Infect Microbiol; 2022; 12():903570. PubMed ID: 35795187
[TBL] [Abstract][Full Text] [Related]
13. The role of the gut microbiota in health and cardiovascular diseases.
Wang L; Wang S; Zhang Q; He C; Fu C; Wei Q
Mol Biomed; 2022 Oct; 3(1):30. PubMed ID: 36219347
[TBL] [Abstract][Full Text] [Related]
14. The Role of Intestinal Flora and Its Metabolites in Heart Failure.
Guan X; Sun Z
Infect Drug Resist; 2023; 16():51-64. PubMed ID: 36636378
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance and potential role of trimethylamine N-oxide in neurological and neuropsychiatric disorders.
Mudimela S; Vishwanath NK; Pillai A; Morales R; Marrelli SP; Barichello T; Giridharan VV
Drug Discov Today; 2022 Nov; 27(11):103334. PubMed ID: 35998800
[TBL] [Abstract][Full Text] [Related]
16. The Relationship Between Atrial Fibrillation and Intestinal Flora With Its Metabolites.
Lu D; Zou X; Zhang H
Front Cardiovasc Med; 2022; 9():948755. PubMed ID: 35845042
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic Review on the Role of Gut Microbiota in the Pathology of Cardiovascular Diseases.
Usman I; Anwar A; Shukla S; Pathak P
Cardiovasc Hematol Disord Drug Targets; 2024 Jun; ():. PubMed ID: 38879769
[TBL] [Abstract][Full Text] [Related]
18. The Gut-Heart Axis: Updated Review for The Roles of Microbiome in Cardiovascular Health.
Bui TVA; Hwangbo H; Lai Y; Hong SB; Choi YJ; Park HJ; Ban K
Korean Circ J; 2023 Aug; 53(8):499-518. PubMed ID: 37525495
[TBL] [Abstract][Full Text] [Related]
19. Interactions between polysaccharides and gut microbiota: A metabolomic and microbial review.
Zhang D; Liu J; Cheng H; Wang H; Tan Y; Feng W; Peng C
Food Res Int; 2022 Oct; 160():111653. PubMed ID: 36076442
[TBL] [Abstract][Full Text] [Related]
20. Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis: From Mechanism to Therapy.
Wang B; Qiu J; Lian J; Yang X; Zhou J
Front Cardiovasc Med; 2021; 8():723886. PubMed ID: 34888358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
